Literature DB >> 22820810

Introduction of rapid syphilis testing within prevention of mother-to-child transmission of HIV programs in Uganda and Zambia: a field acceptability and feasibility study.

Susan Strasser1, Edward Bitarakwate, Michelle Gill, Heather J Hoffman, Othiniel Musana, Anne Phiri, Katharine D Shelley, Tabitha Sripipatana, Alexander Tshaka Ncube, Namwinga Chintu.   

Abstract

BACKGROUND: Given that integration of syphilis testing into prevention of mother-to-child transmission of HIV (PMTCT) programs can prevent adverse pregnancy outcomes, this study assessed feasibility and acceptability of introducing rapid syphilis testing (RST) into PMTCT services.
METHODS: RST was introduced into PMTCT programs in Zambia and Uganda. Using a pre-post intervention design, HIV and syphilis testing and treatment rates during the intervention were compared with baseline.
RESULTS: In Zambia, comparing baseline and intervention, 12,761 of 15,967 (79.9%) and 11,460 of 11,985 (95.6%) first-time antenatal care (ANC) attendees were tested for syphilis (P < 0.0001), 523 of 12,761 (4.1%) and 1050 of 11,460 (9.2%) women tested positive (P < 0.0001); and 267 of 523 (51.1%) and 1000 of 1050 (95.2%) syphilis-positive women were treated (P < 0.0001), respectively. Comparing baseline and intervention, 7479 of 7830 (95.5%) and 11,151 of 11,409 (97.7%) of ANC attendees were tested for HIV (P < 0.0001) and 1303 of 1326 (98.3%) and 2036 of 2034 (100.1%) of those testing positive received combination antiretroviral drugs or single-dose nevirapine prophylaxis (P < 0.0001). In Uganda, 13,131 of 14,540 (90.3%) women were tested for syphilis during intervention, with 690 of 13,131 (5.3%) positive and 715 of 690 (103.6%) treated. Syphilis baseline data were collected, but not included in analysis, as ANC syphilis testing before the study was not consistently practiced. Comparing baseline and intervention, 6479 of 6776 (95.6%) and 11,192 of 11,610 (96.4%) ANC attendees were tested for HIV (P = 0.0009) and 570 of 726 (78.5%) and 964 of 1153 (83.6%) received combination or single-dose prophylaxis (P = 0.007). In Zambia, 254 of 1050 (24.2%) syphilis-positive pregnant women were HIV-positive and 99 of 690 (14.3%) in Uganda.
CONCLUSIONS: Integrating RST in PMTCT programs increases screening and treatment for syphilis among HIV-positive pregnant women and does not compromise HIV services.

Entities:  

Mesh:

Year:  2012        PMID: 22820810     DOI: 10.1097/QAI.0b013e318267bc94

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  34 in total

Review 1.  The introduction of syphilis point of care tests in resource limited settings.

Authors:  Michael Marks; David Cw Mabey
Journal:  Expert Rev Mol Diagn       Date:  2017-03-14       Impact factor: 5.225

2.  Field Evaluation of a Dual Rapid Immunodiagnostic Test for HIV and Syphilis Infection in Peru.

Authors:  Claire C Bristow; Segundo R Leon; Emily Huang; Lourdes B Ramos; Silver K Vargas; Juan A Flores; Kelika A Konda; Carlos F Caceres; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2016-01       Impact factor: 2.830

3.  Uptake of Home-Based Syphilis and Human Immunodeficiency Virus Testing Among Male Partners of Pregnant Women in Western Kenya.

Authors:  Jennifer Mark; John Kinuthia; Alison C Roxby; Daisy Krakowiak; Alfred Osoti; Barbra A Richardson; Molly Ann Gone; Victor Asila; Saloni Parikh; Carey Farquhar
Journal:  Sex Transm Dis       Date:  2017-09       Impact factor: 2.830

Review 4.  Prevalence of Curable Sexually Transmitted Infections in Pregnant Women in Low- and Middle-Income Countries From 2010 to 2015: A Systematic Review.

Authors:  D L Joseph Davey; H I Shull; J D Billings; D Wang; K Adachi; J D Klausner
Journal:  Sex Transm Dis       Date:  2016-07       Impact factor: 2.830

5.  Acceptability and Feasibility of Rapid Chlamydial, Gonococcal, and Trichomonal Screening and Treatment in Pregnant Women in 6 Low- to Middle-Income Countries.

Authors:  Chelsea Lee Shannon; Claire Bristow; Nicole Hoff; Adriane Wynn; Minh Nguyen; Andrew Medina-Marino; Jeanne Cabeza; Anne Rimoin; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2018-10       Impact factor: 2.830

Review 6.  Facilitators and barriers to point-of-care testing for sexually transmitted infections in low- and middle-income countries: a scoping review.

Authors:  Kevin Martin; Rhys Wenlock; Tom Roper; Ceri Butler; Jaime H Vera
Journal:  BMC Infect Dis       Date:  2022-06-20       Impact factor: 3.667

Review 7.  Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control.

Authors:  Joseph D Tucker; Cedric H Bien; Rosanna W Peeling
Journal:  Curr Opin Infect Dis       Date:  2013-02       Impact factor: 4.915

8.  Estimating the Public Health Burden Associated With Adverse Pregnancy Outcomes Resulting From Syphilis Infection Across 43 Countries in Sub-Saharan Africa.

Authors:  Andreas Kuznik; Abdulrazaq G Habib; Yukari C Manabe; Mohammed Lamorde
Journal:  Sex Transm Dis       Date:  2015-07       Impact factor: 2.830

9.  Point-of-care tests for sexually transmissible infections: what do 'end users' want?

Authors:  Anne M Rompalo; Yu-Hsiang Hsieh; Terry Hogan; Mathilda Barnes; Mary Jett-Goheen; Jill S Huppert; Charlotte A Gaydos
Journal:  Sex Health       Date:  2013-12       Impact factor: 2.706

10.  Field performance evaluation of dual rapid HIV and syphilis tests in three antenatal care clinics in Zambia.

Authors:  Margaret P Kasaro; Samuel Bosomprah; Melanie M Taylor; Ntazana Sindano; Caroline Phiri; Bushimbwa Tambatamba; Sarai Malumo; Bethany Freeman; Bertha Chibwe; Maura Laverty; Morkor N Owiredu; Lori Newman; Izukanji Sikazwe
Journal:  Int J STD AIDS       Date:  2018-11-25       Impact factor: 1.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.